Joan Puig de Dou
- Active in the pharmaceutical marketing for over 30 years
- President of CataloniaBIO&HealthTech
- CEO and Qualified Person at Kymos
- Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications.
Experience
Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&HealthTech to represent the Catalonian biotech industry nationally and internationally.
Expertise
Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader’s level of expertise. He publishes regularely on Kymos’ webpage, social media and in the specialized press.
Education
He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School’s Programa Diección General (PDG)
Want to know him better?
Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Scíentific de Barcelona.
ICH M10 Comparison with EMA and FDA Past Guidelines on Bioanalytical Method Validation
Although the ICH has published recommendations for the validation of analytical methods used in the evaluation of the quality of drugs and active substances (ICH Q2) for more than 25 years, it was not until (...) Read more
Kymos and Prolytic are CIR certified
In addition to Kymos, which has been CIR certified for quite some time, our German subsidiary Prolytic has been approved a CIR certification as well. Now your R&D activities (from Early Phase up to Phase (...) Read more
Bioequivalence studies in Europe
Bioequivalence studies are designed to show that two drugs are equivalent and substitutable. - But even though the medicines are replaceable, the providers of bioequivalence studies are not. Digna Tost, Department Manager of Bioanalysis (...) Read more
KOREA PHARM & BIO: Goyang, KR | 23-26 Apr 2024
BIO KOREA 2024: Seoul, KR | 08-10 May 2024
BIO International Convention: San Diego, US | 3-6 Jun 2024
Congrès POLEPHARMA Biotesting: Évreux, FR | 5-6 Jun 2024
AFI Symposium: Rimini, IT | 5-7 Jun 2024
BIOPLUS – INTERPHEX KOREA: Seoul, KR | 10-12 Jul 2024
Farmaforum: Madrid, ES | 25-26 Sep 2024
Biomarkers Europe 2024: Basel, CH | 30 Sep – 01 Oct 2024
CPHI 2024: Milan, IT | 8-10 Oct 2024
BIO-Europe Autumn: Stockholm, SE | 4-6 Nov 2024
European Bioanalysis Forum: Barcelona, ES | 20-22 Nov 2024
PharmaLab Congress: Düsseldorf, DE | 25-27 Nov 2024
I4ID 2024: Lyon, FR | 27-28 Nov 2024